3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione

C200H198N24O25P8 — CID 161349368

IUPAC3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione
SMILESCOc1ccc(N2CCN(c3ccc(C)cc3)P2(=O)C2CC(=O)N(c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2CCN(c3ccc(C)cc3)P2(=O)C2CC(=O)N(c3ccccc3)C2=O)cc1.O=C1CC(P2(=O)N(c3ccccc3)CCN2c2ccccc2)C(=O)N1C1CCCCC1.O=C1CC(P2(=O)N(c3ccccc3)CCN2c2ccccc2)C(=O)N1c1ccccc1
InChIInChI=1S/C26H26N3O4P.C26H26N3O3P.4C25H24N3O3P.C24H28N3O3P.C24H22N3O3P/c1-19-8-10-20(11-9-19)27-16-17-28(21-12-14-23(33-2)15-13-21)34(27,32)24-18-25(30)29(26(24)31)22-6-4-3-5-7-22;1-19-8-12-21(13-9-19)27-16-17-28(22-14-10-20(2)11-15-22)33(27,32)24-18-25(30)29(26(24)31)23-6-4-3-5-7-23;4*1-19-12-14-22(15-13-19)28-24(29)18-23(25(28)30)32(31)26(20-8-4-2-5-9-20)16-17-27(32)21-10-6-3-7-11-21;2*28-23-18-22(24(29)27(23)21-14-8-3-9-15-21)31(30)25(19-10-4-1-5-11-19)16-17-26(31)20-12-6-2-7-13-20/h3-15,24H,16-18H2,1-2H3;3-15,24H,16-18H2,1-2H3;4*2-15,23H,16-18H2,1H3;1-2,4-7,10-13,21-22H,3,8-9,14-18H2;1-15,22H,16-18H2
InChIKeyVNSRNVXNBYTAQN-UHFFFAOYSA-N
MW3585.72 g/mol
LogP38.60
Rot. Bonds33

About 3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione

3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione (PubChem CID 161349368) has the molecular formula C200H198N24O25P8 and a molecular weight of 3585.72 g/mol. Its IUPAC name is 3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione.

Molecular Properties

Compound Name3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione
PubChem CID161349368
Molecular FormulaC200H198N24O25P8
Molecular Weight3585.72 g/mol
Exact Mass3583.29
IUPAC Name3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione
SMILESCOc1ccc(N2CCN(c3ccc(C)cc3)P2(=O)C2CC(=O)N(c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2CCN(c3ccc(C)cc3)P2(=O)C2CC(=O)N(c3ccccc3)C2=O)cc1.O=C1CC(P2(=O)N(c3ccccc3)CCN2c2ccccc2)C(=O)N1C1CCCCC1.O=C1CC(P2(=O)N(c3ccccc3)CCN2c2ccccc2)C(=O)N1c1ccccc1
InChIInChI=1S/C26H26N3O4P.C26H26N3O3P.4C25H24N3O3P.C24H28N3O3P.C24H22N3O3P/c1-19-8-10-20(11-9-19)27-16-17-28(21-12-14-23(33-2)15-13-21)34(27,32)24-18-25(30)29(26(24)31)22-6-4-3-5-7-22;1-19-8-12-21(13-9-19)27-16-17-28(22-14-10-20(2)11-15-22)33(27,32)24-18-25(30)29(26(24)31)23-6-4-3-5-7-23;4*1-19-12-14-22(15-13-19)28-24(29)18-23(25(28)30)32(31)26(20-8-4-2-5-9-20)16-17-27(32)21-10-6-3-7-11-21;2*28-23-18-22(24(29)27(23)21-14-8-3-9-15-21)31(30)25(19-10-4-1-5-11-19)16-17-26(31)20-12-6-2-7-13-20/h3-15,24H,16-18H2,1-2H3;3-15,24H,16-18H2,1-2H3;4*2-15,23H,16-18H2,1H3;1-2,4-7,10-13,21-22H,3,8-9,14-18H2;1-15,22H,16-18H2
InChIKeyVNSRNVXNBYTAQN-UHFFFAOYSA-N
XLogP38.60
TPSA496.67 Ų
H-Bond Donors
H-Bond Acceptors25
Rotatable Bonds33
Heavy Atoms257
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003585.72
LogP ≤ 538.60
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione?
The IUPAC name of 3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione (CID 161349368) is 3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione.
What is the SMILES notation for 3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione?
The canonical SMILES for 3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione is COc1ccc(N2CCN(c3ccc(C)cc3)P2(=O)C2CC(=O)N(c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2C(=O)CC(P3(=O)N(c4ccccc4)CCN3c3ccccc3)C2=O)cc1.Cc1ccc(N2CCN(c3ccc(C)cc3)P2(=O)C2CC(=O)N(c3ccccc3)C2=O)cc1.O=C1CC(P2(=O)N(c3ccccc3)CCN2c2ccccc2)C(=O)N1C1CCCCC1.O=C1CC(P2(=O)N(c3ccccc3)CCN2c2ccccc2)C(=O)N1c1ccccc1.
What is the InChIKey of 3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione?
The InChIKey is VNSRNVXNBYTAQN-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26N3O4P.C26H26N3O3P.4C25H24N3O3P.C24H28N3O3P.C24H22N3O3P/c1-19-8-10-20(11-9-19)27-16-17-28(21-12-14-23(33-2)15-13-21)34(27,32)24-18-25(30)29(26(24)31)22-6-4-3-5-7-22;1-19-8-12-21(13-9-19)27-16-17-28(22-14-10-20(2)11-15-22)33(27,32)24-18-25(30)29(26(24)31)23-6-4-3-5-7-23;4*1-19-12-14-22(15-13-19)28-24(29)18-23(25(28)30)32(31)26(20-8-4-2-5-9-20)16-17-27(32)21-10-6-3-7-11-21;2*28-23-18-22(24(29)27(23)21-14-8-3-9-15-21)31(30)25(19-10-4-1-5-11-19)16-17-26(31)20-12-6-2-7-13-20/h3-15,24H,16-18H2,1-2H3;3-15,24H,16-18H2,1-2H3;4*2-15,23H,16-18H2,1H3;1-2,4-7,10-13,21-22H,3,8-9,14-18H2;1-15,22H,16-18H2.
What are the key properties of 3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione?
3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione has a molecular weight of 3585.72 g/mol, XLogP of 38.60, 33 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[1,3-bis(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;1-cyclohexyl-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione;3-[1-(4-methoxyphenyl)-3-(4-methylphenyl)-2-oxo-1,3,2λ5-diazaphospholidin-2-yl]-1-phenylpyrrolidine-2,5-dione;tetrakis(1-(4-methylphenyl)-3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)pyrrolidine-2,5-dione);3-(2-oxo-1,3-diphenyl-1,3,2λ5-diazaphospholidin-2-yl)-1-phenylpyrrolidine-2,5-dione is sourced from PubChem (CID 161349368), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).